Neuroimaging Markers of Emerging Dysfunction In Preclinical Alzheimer Disease
Neuroimaging Markers of Emerging Dysfunction In Preclinical Alzheimer Disease
批准号:
9312558
负责人:
BRIAN Andrew GORDON
金额:
$12.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-15 至 2022-04-30
关键词:
Alzheimer&aposs DiseaseAttentionBiologicalBiological AssayBiological MarkersBrainCerebrospinal FluidClinicalClinical TrialsClinical assessmentsCognitionCognitiveCognitive deficitsCohort StudiesDataDementiaDevelopmentDiagnosticDiseaseDorsalElderlyEpisodic memoryFaceFunctional Magnetic Resonance ImagingFunctional disorderFutureGoalsImageImpaired cognitionImpairmentIndividualInterventionKnowledgeMapsMeasuresMedialMediatingMemoryMinorNamesNeurobehavioral ManifestationsNeuronsNeuropsychological TestsNormalcyOutcomeParticipantPathologic ProcessesPathologyPatternPhasePositron-Emission TomographyPrefrontal CortexRecruitment ActivityResearchResearch PersonnelRestRiskSamplingScanningSenile dementiaShort-Term MemoryStressSupport SystemSymptomsTechniquesTemporal LobeTimeTrainingWorkanalytical toolattentional controlbasebrain healthcognitive neurosciencecognitive processcognitive taskcognitive testingdementedhealthy agingimprovedin vivoinnovationlong term memorylongitudinal designmemory encodingneuroimagingneuroimaging markeroutcome forecastpre-clinicalrelating to nervous systemskillssupport networktool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this proposal is to support the candidate's development and transition
into an independent researcher. The outlined training plan will equip the applicant with
the necessary skills to conduct innovative work that spans both primary research and
clinical domains. The accrual of Alzheimer's disease (AD) pathology can begin decades
before the onset of cognitive symptoms. Higher levels of pathology increase the risk of
dementia, but the relationship between pathology and cognition is imperfect. Functional
magnetic resonance imaging (fMRI) provides a way to non-invasively assess the
integrity of networks in the brain that support cognition. As such it may provide a better
measure of the brain's health than biomarkers of pathology alone. Prior work using fMRI
has almost exclusively utilized only episodic memory tasks. This approach is limited as
AD leads to deficits beyond memory domains. The goal of Aim 1 is to characterize
alterations in neural activity related to preclinical levels of AD pathology using three
tasks that respectively target attentional control, working memory, and episodic memory.
The goal of Aim 2 is to compare the sensitivity of these task-based fMRI paradigms to
resting-state fMRI. The goal of Aim 3 is to relate task-based fMRI data to longitudinal
cognition and the transition from cognitive normality to an impaired state. This work will
improve our understanding of the relationship between AD pathology and neuronal
activity, as well as the relationship between such fMRI activity and longitudinal cognition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuroimaging Markers of Emerging Dysfunction In Preclinical Alzheimer Disease
-
批准号:9910360
-
项目类别:
-
资助金额:$12.46万
-
财政年份:2017
-
负责人:BRIAN Andrew GORDON
-
依托单位:
Dominantly Inherited Alzheimer Network: Project 2
-
批准号:10462566
-
项目类别:
-
资助金额:$78.66万
-
财政年份:2008
-
负责人:BRIAN Andrew GORDON
-
依托单位:
Dominantly Inherited Alzheimer Network: Project 2
-
批准号:10225489
-
项目类别:
-
资助金额:$99.37万
-
财政年份:2008
-
负责人:BRIAN Andrew GORDON
-
依托单位:
Dominantly Inherited Alzheimer Network: Project 2
-
批准号:10017844
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2008
-
负责人:BRIAN Andrew GORDON
-
依托单位:
Dominantly Inherited Alzheimer Network: Project 2
-
批准号:10665747
-
项目类别:
-
资助金额:$53.42万
-
财政年份:2008
-
负责人:BRIAN Andrew GORDON
-
依托单位:
Dominantly Inherited Alzheimer Network: Project 2
-
批准号:9790621
-
项目类别:
-
资助金额:$30.34万
-
财政年份:--
-
负责人:BRIAN Andrew GORDON
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: